Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Praful Ravi

Showing results (1-10 of 101) with videos related to

Pageof 11
Sort By:
Therapeutic Advances in Medical Oncology|January 15, 2026
Current and future perspectives on radioligand therapy in advanced prostate cancerBuraq Ahmed, Praful Ravi
Expert Opinion on Biological Therapy|June 27, 2020
Antibody-drug conjugates for the treatment of urothelial carcinomaPraful Ravi, Bradley A McGregor
Expert Opinion on Pharmacotherapy|September 1, 2020
Considerations in prescribing pharmacotherapy for localized and metastatic urothelial carcinomaPraful Ravi, Guru P Sonpavde
The Urologic Clinics of North America|October 9, 2016
Multimodal Therapy in the Management of Advanced Penile CancerPraful Ravi, Lance C Pagliaro
European Urology Focus|January 15, 2023
Defining Patient Benefits from High-intensity Intermittent Therapy for Hormone-sensitive Prostate CancerPraful Ravi, Atish D Choudhury
Mayo Clinic Proceedings|November 17, 2017
47-Year-Old Woman With Anemia and ThrombocytopeniaPraful Ravi, Roberto Leon-Ferre, Carrie A Thompson
Expert Review of Anticancer Therapy|October 28, 2022
Lutetium Lu 177 vipivotide tetraxetan for metastatic castration-resistant prostate cancerHina Shah, Praful Ravi, Guru Sonpavde, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 23, 2024
Delaying Prostate-Specific Antigen Progression in Biochemically Recurrent Prostate Cancer: Is It Clinically Meaningful?Daniel S Childs, Jacob J Orme, Praful Ravi
European Urology Focus|May 25, 2026
NCCN Guideline Updates on Radiopharmaceutical Therapy for Prostate CancerPraful Ravi, Tanya Barauskas Dorff, Alicia K Morgans
Cancer Journal (Sudbury, Mass.)|September 18, 2020
Novel Therapeutic Approaches and the Evolution of Drug Development in Advanced Kidney CancerPraful Ravi, Ziad Bakouny, Andrew Schmidt, et al.
Pageof 11

Showing results (1-10 of 101) with videos related to

Sort By:
Pageof 11
Therapeutic Advances in Medical Oncology|January 15, 2026
Current and future perspectives on radioligand therapy in advanced prostate cancerBuraq Ahmed, Praful Ravi
Expert Opinion on Biological Therapy|June 27, 2020
Antibody-drug conjugates for the treatment of urothelial carcinomaPraful Ravi, Bradley A McGregor
Expert Opinion on Pharmacotherapy|September 1, 2020
Considerations in prescribing pharmacotherapy for localized and metastatic urothelial carcinomaPraful Ravi, Guru P Sonpavde
The Urologic Clinics of North America|October 9, 2016
Multimodal Therapy in the Management of Advanced Penile CancerPraful Ravi, Lance C Pagliaro
European Urology Focus|January 15, 2023
Defining Patient Benefits from High-intensity Intermittent Therapy for Hormone-sensitive Prostate CancerPraful Ravi, Atish D Choudhury
Mayo Clinic Proceedings|November 17, 2017
47-Year-Old Woman With Anemia and ThrombocytopeniaPraful Ravi, Roberto Leon-Ferre, Carrie A Thompson
Expert Review of Anticancer Therapy|October 28, 2022
Lutetium Lu 177 vipivotide tetraxetan for metastatic castration-resistant prostate cancerHina Shah, Praful Ravi, Guru Sonpavde, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 23, 2024
Delaying Prostate-Specific Antigen Progression in Biochemically Recurrent Prostate Cancer: Is It Clinically Meaningful?Daniel S Childs, Jacob J Orme, Praful Ravi
European Urology Focus|May 25, 2026
NCCN Guideline Updates on Radiopharmaceutical Therapy for Prostate CancerPraful Ravi, Tanya Barauskas Dorff, Alicia K Morgans
Cancer Journal (Sudbury, Mass.)|September 18, 2020
Novel Therapeutic Approaches and the Evolution of Drug Development in Advanced Kidney CancerPraful Ravi, Ziad Bakouny, Andrew Schmidt, et al.
Pageof 11